OVID THERAPEUTICS INC. 690469101 07/09/2025 Advisory approval of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3853818 0 ABSTAIN 3853818 FOR 1 ESSA PHARMA INC. 29668H708 10/03/2025 To consider, and, if thought advisable, to pass, an ordinary resolution to approve, on an advisory and non-binding basis, the compensation to be paid or become payable to its named executive officers that is based on or otherwise relates to the Arrangement, all as more particularly described in the Circular and Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 8748629 0 FOR 8748629 FOR 1 ZYMEWORKS INC. 98985Y108 12/30/2025 Advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 3938641 0 FOR 3938641 FOR 1 REPARE THERAPEUTICS INC. 760273102 01/16/2026 An ordinary resolution to approve, on an advisory and non-binding basis, the compensation to be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Arrangement (the "Compensation Resolution"). SECTION 14A SAY-ON-PAY VOTES ISSUER 10333600 0 FOR 10333600 FOR 1 X4 PHARMACEUTICALS, INC. 98420X202 05/11/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2233742 0 FOR 2233742 FOR 1 XOMA ROYALTY CORP. 98419J206 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2590303 0 FOR 2590303 FOR 1 IMMUNOCORE HOLDINGS PLC 45258D105 05/27/2026 To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1294463 0 FOR 1294463 FOR 1 CRESCENT BIOPHARMA, INC. G2545C104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1387863 0 FOR 1387863 FOR 1 CRESCENT BIOPHARMA, INC. G2545C104 06/02/2026 To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve compensation for Crescent Biopharma, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1387863 0 1-YR 1387863 FOR 1 STOKE THERAPEUTICS, INC. 86150R107 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2547557 0 FOR 2547557 FOR 1 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 8445769 0 ABSTAIN 8445769 FOR 1 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8445769 0 ABSTAIN 8445769 FOR 1 NEKTAR THERAPEUTICS 640268306 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 2559595 0 FOR 2559595 FOR 1 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 16001284 0 FOR 16001284 FOR 1 SUTRO BIOPHARMA, INC. 869367201 06/05/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1251788 0 FOR 1251788 FOR 1 COMPASS THERAPEUTICS, INC. 20454B104 06/10/2026 To approve, on a non-binding, advisory basis, the holding of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7764842 0 1-YR 7764842 FOR 1 COMPASS THERAPEUTICS, INC. 20454B104 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7764842 0 FOR 7764842 FOR 1 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 960989 0 FOR 960989 FOR 1 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 960989 0 1-YR 960989 FOR 1 ANNEXON, INC. 03589W102 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8698173 0 FOR 8698173 FOR 1 MIRUM PHARMACEUTICALS, INC. 604749101 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1259727 0 FOR 1259727 FOR 1 XENCOR, INC. 98401F105 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 7133720 0 FOR 7133720 FOR 1 CULLINAN THERAPEUTICS, INC. 230031106 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4362044 0 FOR 4362044 FOR 1 OLEMA PHARMACEUTICALS, INC. 68062P106 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5295893 0 FOR 5295893 FOR 1 4D MOLECULAR THERAPEUTICS, INC. 35104E100 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 2879289 0 FOR 2879289 FOR 1 STRUCTURE THERAPEUTICS, INC. 86366E106 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3459358 0 FOR 3459358 FOR 1 DISC MEDICINE, INC. 254604101 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1272312 0 FOR 1272312 FOR 1 REVOLUTION MEDICINES, INC. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 3581782 0 FOR 3581782 FOR 1 KYMERA THERAPEUTICS, INC. 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5502710 0 FOR 5502710 FOR 1 FOGHORN THERAPEUTICS INC. 344174107 06/24/2026 To approve, on an advisory basis, the compensation of Foghorn's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5842000 0 FOR 5842000 FOR 1 FOGHORN THERAPEUTICS INC. 344174107 06/24/2026 To approve, on an advisory basis, the frequency of future advisory votes on the compensation of Foghorn's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5842000 0 1-YR 5842000 FOR 1